Ottobock SE & Co. KGaA Net Assets
Ottobock SE & Co. KGaA net assets. Based on the latest financial reports, Ottobock SE & Co. KGaA (OBCK) has net assets worth €402.20 Million EUR (≈ $470.21 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.26 Billion ≈ $2.64 Billion USD) and total liabilities (€1.85 Billion ≈ $2.17 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore Ottobock SE & Co. KGaA capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €402.20 Million |
| % of Total Assets | 17.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Net Assets of Ottobock SE & Co. KGaA (2025–2025)
Net assets of Ottobock SE & Co. KGaA from 2025 to 2025. This chart illustrates how Ottobock SE & Co. KGaA's net assets have evolved over time, based on quarterly financial data. See OBCK equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Ottobock SE & Co. KGaA (2025–2025)
The table below shows the annual net assets of Ottobock SE & Co. KGaA from 2025 to 2025. For live market cap and overall valuation, see Ottobock SE & Co. KGaA stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €397.50 Million ≈ $464.72 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ottobock SE & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Ottobock SE & Co. KGaA Net Assets Breakdown (December 2025)
Ottobock SE & Co. KGaA net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €223.40 Million | 57.27% |
| Other Components | €166.70 Million | 42.73% |
| Total Equity | €390.10 Million | 100.00% |
Ottobock SE & Co. KGaA Competitors by Market Cap
The table below lists competitors of Ottobock SE & Co. KGaA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Welspun Living Limited
NSE:WELSPUNLIV
|
$2.54 Billion |
|
Four Corners Property Trust Inc
NYSE:FCPT
|
$2.54 Billion |
|
Qingdao Hanhe Cable Co Ltd
SHE:002498
|
$2.55 Billion |
|
Asmedia Technology Inc
TW:5269
|
$2.55 Billion |
|
People.Cn Co Ltd
SHG:603000
|
$2.54 Billion |
|
Sumber Alfaria Trijaya Tbk
JK:AMRT
|
$2.54 Billion |
|
Maple Leaf Foods Inc.
TO:MFI
|
$2.54 Billion |
|
First Merchants Corporation
NASDAQ:FRME
|
$2.54 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ottobock SE & Co. KGaA's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Ottobock SE & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.44x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2025-12-31 | €6.10 | €39.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ottobock SE & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.12%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.37%
- • Asset Turnover: 0.82x
- • Equity Multiplier: 5.25x
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2025 | 23.12% | 5.37% | 0.82x | 5.25x | €51.19 Million |
Industry Comparison
This section compares Ottobock SE & Co. KGaA's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,810,607,466
- Average return on equity (ROE) among peers: -86.21%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ottobock SE & Co. KGaA (OBCK) | €402.20 Million | 23.12% | 4.61x | $2.54 Billion |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $315.66 Million | 24.55% | 0.89x | $2.39 Billion |
| CONVATEC GRP UNSP.ADR /4 (2CVU) | $1.61 Billion | 3.91% | 1.23x | $5.07 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $2.67 Billion | 11.61% | 1.89x | $17.02 Billion |
| MEDIMI AB AK (79T) | $332.69K | -959.52% | 4.12x | $1.70 Million |
| TEVANO SYSTEMS HLDGS INC. (7RBA) | $-1.31 Million | 0.00% | 0.00x | $210.67K |
| STEVANATO GROUP SPA O.N. (87N) | $1.13 Billion | 12.86% | 0.83x | $1.05 Billion |
| Carl Zeiss Meditec AG (AFX) | $2.03 Billion | 14.48% | 0.39x | $2.23 Billion |
| CARL ZEISS MEDITEC ADR 1 (AFXA) | $2.17 Billion | 13.36% | 0.40x | $2.14 Billion |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $7.12 Million |
| COLOPLAST SP.ADR 1/10 DK1 (CBH) | $8.17 Billion | 59.07% | 0.94x | $12.73 Billion |
About Ottobock SE & Co. KGaA
Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of p… Read more